Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
PUT
Bank of Montreal
BMO
$129B
| $31.4M | 0.01% |
326,300
-9,100
| -3% | -$967K |
|
1377
PUT
CRISPR Therapeutics
CRSP
$5.16B
| $31.4M | 0.01% |
515,900
+45,400
| +10% | +$2.67M |
|
|
ACLX
1378
DELISTED
Arcellx
ACLX
| $31.3M | 0.01% |
1,769,400
+450,374
| +34% | +$5.81M |
|
1379
Best Buy
BBY
$18.2B
| $31.2M | 0.01% |
478,956
+424,459
| +779% | +$35.4M |
|
1380
CALL
Kinder Morgan
KMI
$72.9B
| $31.2M | 0.01% |
1,862,300
-508,600
| -21% | -$9.52M |
|
1381
Intercontinental Exchange
ICE
$86.6B
| $31.1M | 0.01% |
331,230
-1,498
| -0.5% | -$160K |
|
1382
Devon Energy
DVN
$49.9B
| $31.1M | 0.01% |
565,103
+341,498
| +153% | +$22.3M |
|
1383
Dover
DOV
$28B
| $31.1M | 0.01% |
256,645
+146,809
| +134% | +$19.9M |
|
1384
PUT
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $31.1M | 0.01% |
150,700
-19,200
| -11% | -$4.28M |
|
1385
Regency Centers
REG
$14.1B
| $31.1M | 0.01% |
524,217
+196,775
| +60% | +$13M |
|
1386
CALL
Becton Dickinson
BDX
$49.9B
| $31.1M | 0.01% |
126,100
-41,283
| -25% | -$10.5M |
|
1387
PUT
Carvana
CVNA
$81.9B
| $31.1M | 0.01% |
6,883,500
+2,254,000
| +49% | +$23.7M |
|
1388
PUT
Dominion Energy
D
$60.6B
| $30.9M | 0.01% |
387,100
-685,200
| -64% | -$56.6M |
|
1389
Peabody Energy
BTU
$3.08B
| $30.8M | 0.01% |
1,446,015
+565,564
| +64% | +$13.9M |
|
1390
Akamai
AKAM
$18B
| $30.8M | 0.01% |
337,034
+149,862
| +80% | +$15.6M |
|
1391
PUT
Canadian Natural Resources
CNQ
$99.5B
| $30.8M | 0.01% |
1,169,862
+48,600
| +4% | +$1.48M |
|
1392
Brown-Forman Class B
BF.B
$13B
| $30.7M | 0.01% |
437,575
+377,889
| +633% | +$25.3M |
|
1393
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.04B
| $30.7M | 0.01% |
+1,577,258
| New | +$31.6M |
|
1394
General Motors
GM
$76.2B
| $30.7M | 0.01% |
966,291
-3,755,792
| -80% | -$141M |
|
1395
PUT
iShares Core S&P 500 ETF
IVV
$909B
| $30.7M | 0.01% |
80,900
-97,900
| -55% | -$40.3M |
|
1396
PUT
Pool Corp
POOL
$7.15B
| $30.7M | 0.01% |
87,300
+47,900
| +122% | +$19M |
|
|
P
1397
CALL
Everpure Inc
P
$39B
| $30.6M | 0.01% |
1,190,800
+777,000
| +188% | +$21.5M |
|
1398
Church & Dwight Co
CHD
$24B
| $30.6M | 0.01% |
329,916
+228,318
| +225% | +$21.6M |
|
1399
CALL
iShares Russell 1000 Growth ETF
IWF
$128B
| $30.5M | 0.01% |
558,400
+238,800
| +75% | +$14.3M |
|
1400
Advanced Drainage Systems
WMS
$11.3B
| $30.4M | 0.01% |
337,529
-273,507
| -45% | -$28.1M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.